Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXZ4XT
|
||||
Drug Name |
N-(1-Methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-4-trifluoromethyl-benzamide
|
||||
Synonyms |
CHEMBL2092865
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C24H18F3N3O2
|
||||
Canonical SMILES |
CN1C(=O)[C@@H](NC(=O)c2ccc(cc2)C(F)(F)F)N=C(c3ccccc3)c4ccccc14
|
||||
InChI |
InChI=1S/C24H18F3N3O2/c1-30-19-10-6-5-9-18(19)20(15-7-3-2-4-8-15)28-21(23(30)32)29-22(31)16-11-13-17(14-12-16)24(25,26)27/h2-14,21H,1H3,(H,29,31)/t21-/m1/s1
|
||||
InChIKey |
AXZHYJFBBATDMR-OAQYLSRUSA-N
|
||||
Target and Pathway | |||||
Target(s) | Gastrin/cholecystokinin type B receptor | Target Info | [1587926] | ||
Cholecystokinin receptor type A | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Gastric Acid Production | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.